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BACKGROUND 
People with head and neck cancer frequently have 
symptoms that are caused by their disease or by 
their treatments, which may significantly impact 
on their quality of life living with and beyond 
cancer.1-5 This international research survey 
captured a self-rating report by people who have 
had radiotherapy (RT) treatment for head and 
neck cancer regarding their experience of oral 
symptoms, including dry mouth (xerostomia). 
ONCOLOGY  •  December 2018 EMJ  EUROPEAN MEDICAL JOURNAL74
METHOD 
This survey was designed by patients, and then 
submitted for ethical approval in collaboration 
with a healthcare researcher. The international 
survey was open to anyone >18 years old who 
had had  treatment for head and neck cancer, 
whether or not they currently had symptoms 
of dry mouth. The electronic survey was in 
English and the ethical permissions granted that 
patients who wished to take part could request 
assistance, if needed, due to illness, fatigue, 
confidence in accessing the internet, or English 
literacy. Participant recruitment was supported 
through a wide range of networks including 
healthcare practitioners, charities, and patient 
support groups. The average time to complete 
the 18-item survey was <10 minutes, including 
both multiple choice and open questions. 
Statistical analysis reflected correlations 
between the participant demographics and 
self-reporting of symptoms. An interpretive 
analysis of free text responses highlighted 
patient values and priorities.
RESULTS 
Over 100 individuals responded to the survey 
from across the UK, USA, Canada, Australia, 
India, and mainland Europe. Almost 75% of 
respondents (74.54%) stated that they had 
experienced dryness in the mouth or throat 
at least 50% of the time over the past 7 days. 
Furthermore, the results demonstrated that few 
respondents had received much information 
about dry mouth; >78% stated they had either 
received very little information or no information 
about the possible symptoms of dry mouth. 
Additionally, 88% of respondents stated that 
their oncologist had given them no advice about 
protecting their salivary glands via protective 
treatments. The analysis demonstrates patterns 
between the patient demographics, types of 
radiotherapy treatments, time since treatment, 
and current symptoms. This is the first time 
that this original dataset was presented. 
The findings also generated insights into the 
self-reported impact of these symptoms on 
patients’ quality of life. 
CONCLUSION 
This study comprises important evidence of 
patients’ experiences and symptoms post-
treatment. The cross-sectional dataset also 
indicates the global view of recent and current 
RT treatment approaches. Future collaborative 
studies between researchers, patient groups, 
and pharmaceutical companies are imperative.
This research was presented by a patient 
advocate. The poster was awarded first prize 
for Best Poster at the ESMO 2018 conference.
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Figure 1: The proportion of total survey responders 
by country.
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